@article{8f5407f03f1241259b729d19562512d0,
title = "Diabetes Technology and Therapy in the Pediatric Age Group",
author = "Maahs, {David M.} and Rayhan Lal and Shlomit Shalitin",
note = "Funding Information: D.M.M. has research support from the NIH, JDRF, NSF, and the Helmsley Charitable Trust, and his institution has research support from Medtronic, Dexcom, Insulet, Bigfoot Biomedical, Tandem, and Roche. He has consulted for Abbott, the Helmsley Charitable Trust, Sanofi, Novo Nordisk, Eli Lilly, and Insulet. Funding Information: R.L. is a Stephen Bechtel Endowed Adult and Pediatric Endocrinology Fellow through the Stanford Child Health Research Institute and is supported by a Diabetes, Endocrinology and Metabolism Training Grant (T32 DK007217) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Dr. Lal has consulted for Gly-Sens Incorporated and Abbott Diabetes Care. S.S. has no competing financial interests. Funding Information: D.M.M. has research support from the NIH, JDRF, NSF, and the Helmsley Charitable Trust, and his institution has research support from Medtronic, Dexcom, Insulet, Bigfoot Biomedical, Tandem, and Roche. He has consulted for Abbott, the Helmsley Charitable Trust, Sanofi, Novo Nordisk, Eli Lilly, and Insulet. R.L. is a Stephen Bechtel Endowed Adult and Pediatric Endocrinology Fellow through the Stanford Child Health Research Institute and is supported by a Diabetes, Endocrinology and Metabolism Training Grant (T32 DK007217) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Dr. Lal has consulted for Gly- Sens Incorporated and Abbott Diabetes Care.",
year = "2019",
month = feb,
doi = "10.1089/dia.2019.2510",
language = "אנגלית",
volume = "21",
pages = "S123--S137",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "S1",
}